Abstract

Adsorption properties of hemodialyzers are traditionally retrieved from diffusive treatments and mainly focused on inflammatory markers and plasma proteins. The possible depurative enhancement of middle and high molecular weight solutes, as well as protein-bound uremic toxins by adsorption in convective treatments, is not yet reported. We used discarded plasma exchanges from uremic patients and out-of-date erythrocytes as a novel in vitro uremic precursor matrix to assess removal and adsorption patterns of distinct material and structure but similar surface hemodialyzers in hemodialysis and on-line hemodiafiltration treatments. We further related the obtained results to the possible underlying membrane pore blocking mechanisms. Convection improved removal but slightly enhanced adsorption in the cellulosic and synthetic dialyzers tested. The polymethylmethacrylate hemodialyzer obtained the highest extracted (Mext\\documentclass[12pt]{minimal} \\usepackage{amsmath} \\usepackage{wasysym} \\usepackage{amsfonts} \\usepackage{amssymb} \\usepackage{amsbsy} \\usepackage{mathrsfs} \\usepackage{upgreek} \\setlength{\\oddsidemargin}{-69pt} \\begin{document}$$M_{ext}$$\\end{document}) and adsorbed (Mads\\documentclass[12pt]{minimal} \\usepackage{amsmath} \\usepackage{wasysym} \\usepackage{amsfonts} \\usepackage{amssymb} \\usepackage{amsbsy} \\usepackage{mathrsfs} \\usepackage{upgreek} \\setlength{\\oddsidemargin}{-69pt} \\begin{document}$$M_{ads}$$\\end{document}) mass values when submitted to hemodiafiltration for all molecules analyzed including albumin (Mext=15.8±3.9\\documentclass[12pt]{minimal} \\usepackage{amsmath} \\usepackage{wasysym} \\usepackage{amsfonts} \\usepackage{amssymb} \\usepackage{amsbsy} \\usepackage{mathrsfs} \\usepackage{upgreek} \\setlength{\\oddsidemargin}{-69pt} \\begin{document}$$M_{ext}=15.8\\pm 3.9$$\\end{document} g, Mads=44.3±11.5\\documentclass[12pt]{minimal} \\usepackage{amsmath} \\usepackage{wasysym} \\usepackage{amsfonts} \\usepackage{amssymb} \\usepackage{amsbsy} \\usepackage{mathrsfs} \\usepackage{upgreek} \\setlength{\\oddsidemargin}{-69pt} \\begin{document}$$M_{ads}=44.3\\pm 11.5$$\\end{document} mg), whereas the polyamide membrane obtained substantial lower results even for this molecule (Mext=2.2±1.2\\documentclass[12pt]{minimal} \\usepackage{amsmath} \\usepackage{wasysym} \\usepackage{amsfonts} \\usepackage{amssymb} \\usepackage{amsbsy} \\usepackage{mathrsfs} \\usepackage{upgreek} \\setlength{\\oddsidemargin}{-69pt} \\begin{document}$$M_{ext}=2.2\\pm 1.2$$\\end{document} g, Mads=4.2±0.7\\documentclass[12pt]{minimal} \\usepackage{amsmath} \\usepackage{wasysym} \\usepackage{amsfonts} \\usepackage{amssymb} \\usepackage{amsbsy} \\usepackage{mathrsfs} \\usepackage{upgreek} \\setlength{\\oddsidemargin}{-69pt} \\begin{document}$$M_{ads}=4.2\\pm 0.7$$\\end{document} mg) under the same treatment parameters. Hemodiafiltration in symmetric and enlarged pore hemodialyzers enhances removal and adsorption by internal pore deposition (intermediate pore-blocking) for middle and high molecular weight toxins but leads to substantial and deleterious albumin depuration.

Highlights

  • Adsorption properties of hemodialyzers are traditionally retrieved from diffusive treatments and mainly focused on inflammatory markers and plasma proteins

  • The evaluation of the depurative enhancement by adsorption in HDF treatments is of keen interest, especially regarding protein-bound uremic toxins such as p-cresyl sulfate (PCs)[22] and indoxyl sulfate (IS)[23], poorly removed by conventional t­echniques[24,25] due to their binding affinity

  • The total extracted ( Mext ) and adsorbed mass ( Mext ) and adsorbed ( (Mads) ) for the different solutes used in the tested hemodialyzers and treatment conditions are depicted in Fig. 1 whereas the concentration decay for each molecule and treatment is given as Supplementary Fig. S1

Read more

Summary

Introduction

Adsorption properties of hemodialyzers are traditionally retrieved from diffusive treatments and mainly focused on inflammatory markers and plasma proteins. The evaluation of the depurative enhancement by adsorption in HDF treatments is of keen interest, especially regarding protein-bound uremic toxins such as p-cresyl sulfate (PCs)[22] and indoxyl sulfate (IS)[23], poorly removed by conventional t­echniques[24,25] due to their binding affinity To this end, we implemented for the first time an original in vitro set-up composed by discarded plasma exchanges from uremic patients and out-of-date erythrocytes as an inexpensive and filled uremic toxin precursor matrix aimed to evaluate the removal and adsorption properties of distinct commercial hemodialyzers (Sureflux21UX by Nipro, CTA; BG-2.1U by Toray, PMMA; Fx-1000 Cordiax by Fresenius, PS and Polyflux-210H by Gambro, PA) submitted to HD and HDF through the quantification of total extracted and adsorbed mass. The understanding of removal and adsorption mechanisms of commercial hemodialyzers are of remarked interest to individualize and optimize the membrane and convective modality selection for each patient

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call